FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

David Penson

Research Profile

Disorders

Concepts & Ideas

Procedures

Activities & Behaviors

Chemicals & Drugs

Prostate Specific Antigen

Geographic Areas

United States

Co-author Network

Publications

TOP 3
Ruth Etzioni; Eric J Feuer; Roman Gulati; E A M Heijnsdijk; Jeffrey Katcher; Harry J de Koning; Gerrit Draisma; David F Penson; Alexander Tsodikov; Elisabeth M Wever; Angela B Mariotto
The prostate cancer conundrum revisited: treatment changes and prostate cancer mortality declines.
Eric J Feuer; Mark Hachey; David Campbell; Ginger A Carter; Kathy A Cronin; Laurie Cynkin; Minjung Lee; Angela Mariotto; David F Penson; Antoinette Percy-Laurry; Deborah Schrag; Steven M Scoppa; Zhaohui Zou; Benjamin F Hankey
The Cancer Survival Query System: making survival estimates from the Surveillance, Epidemiology, and End Results program more timely and relevant for recently diagnosed patients.
Eric J Small; David F Penson; Oliver Sartor
The relationship between symptomatology and treatment selection in metastatic castrate-resistant prostate cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of David Penson (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Ruth Etzioni; Eric J Feuer; Roman Gulati; E A M Heijnsdijk; Jeffrey Katcher; Harry J de Koning; Gerrit Draisma; David F Penson; Alexander Tsodikov; Elisabeth M Wever; Angela B Mariotto
The prostate cancer conundrum revisited: treatment changes and prostate cancer mortality declines.
Cancer 2012;118(23):5955-63.
2012: Eric J Feuer; Mark Hachey; David Campbell; Ginger A Carter; Kathy A Cronin; Laurie Cynkin; Minjung Lee; Angela Mariotto; David F Penson; Antoinette Percy-Laurry; Deborah Schrag; Steven M Scoppa; Zhaohui Zou; Benjamin F Hankey
The Cancer Survival Query System: making survival estimates from the Surveillance, Epidemiology, and End Results program more timely and relevant for recently diagnosed patients.
Cancer 2012;118(22):5652-62.
2011: Eric J Small; David F Penson; Oliver Sartor
The relationship between symptomatology and treatment selection in metastatic castrate-resistant prostate cancer.
Clinical advances in hematology & oncology : H&O 2011;9(7 Suppl 13):1-15.
2011: Roman Gulati; Elisabeth M Wever; Alexander Tsodikov; David F Penson; Lurdes Y T Inoue; Jeffrey Katcher; Shih-Yuan Lee; E A M Heijnsdijk; Gerrit Draisma; Harry J de Koning; Ruth Etzioni
What if i don't treat my PSA-detected prostate cancer? Answers from three natural history models.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2011;20(5):740-50.
2011: Ann S Hamilton; Peter C Albertsen; Terri Kang Johnson; Richard Hoffman; Donna Morrell; Dennis Deapen; David F Penson
Trends in the treatment of localized prostate cancer using supplemented cancer registry data.
BJU international 2011;107(4):576-84.
2009: Harman M Bruins; George J Huang; Jie Cai; Donald G Skinner; John P Stein; David F Penson
Clinical outcomes and recurrence predictors of lymph node positive urothelial cancer after cystectomy.
The Journal of urology 2009;182(5):2182-7.
2009: John P Stein; Richard E Hautmann; David F Penson; Donald G Skinner
Prostate-sparing cystectomy: a review of the oncologic and functional outcomes. Contraindicated in patients with bladder cancer.
Urologic oncology 2009;27(5):466-72.
2009: David F Penson; Hunter Wessells; Patricia Cleary; Brandy N Rutledge
Sexual dysfunction and symptom impact in men with long-standing type 1 diabetes in the DCCT/EDIC cohort.
The journal of sexual medicine 2009;6(7):1969-78.
2009: Michael B Nichol; Tara K Knight; Joanne Wu; Richard Barron; David F Penson
Evaluating use patterns of and adherence to medications for benign prostatic hyperplasia.
The Journal of urology 2009;181(5):2214-21; discussion 2221-2.
2009: John P Stein; David F Penson; Charlotte Lee; Jie Cai; Gus Miranda; Donald G Skinner
Long-term oncological outcomes in women undergoing radical cystectomy and orthotopic diversion for bladder cancer.
The Journal of urology 2009;181(5):2052-8; discussion 2058-9.
2008: David F Penson; Michel Rossignol; A Oliver Sartor; Peter T Scardino; Lucien L Abenhaim
Prostate cancer: epidemiology and health-related quality of life.
Urology 2008;72(6 Suppl):S3-11.
2008: George J Huang; Ann S Hamilton; Mary Lo; John P Stein; David F Penson
Predictors of intravesical therapy for nonmuscle invasive bladder cancer: results from the surveillance, epidemiology and end results program 2003 patterns of care project.
The Journal of urology 2008;180(2):520-4; discussion 524.
2008: John P Stein; David F Penson
Invasive T1 bladder cancer: indications and rationale for radical cystectomy.
BJU international 2008;102(3):270-5.
2008: John P Stein; David F Penson
The invasive T1 bladder tumor: contemporary issues and rationale for radical cystectomy.
Current urology reports 2008;9(3):179-81.
2008: David F Penson; Dale McLerran; Ziding Feng; Lin Li; Peter C Albertsen; Frank D Gilliland; Ann Hamilton; Richard M Hoffman; Robert A Stephenson; Arnold L Potosky; Janet L Stanford
5-year urinary and sexual outcomes after radical prostatectomy: results from the Prostate Cancer Outcomes Study.
The Journal of urology 2008;179(5 Suppl):S40-4.
2008: David F Penson
Assessing the quality of prostate cancer care.
Current opinion in urology 2008;18(3):297-302.
2008: George J Huang; David F Penson
Internet health resources and the cancer patient.
Cancer investigation 2008;26(2):202-7.
2007: David F Penson
Quality of life after therapy for localized prostate cancer.
Cancer journal (Sudbury, Mass.) 2007;13(5):318-26.
2007: John P Stein; David F Penson; Simon D Wu; Donald G Skinner
Pathological guidelines for orthotopic urinary diversion in women with bladder cancer: a review of the literature.
The Journal of urology 2007;178(3 Pt 1):756-60.
2007: David F Penson; June M Chan
Prostate cancer.
The Journal of urology 2007;177(6):2020-9.
2007: John P Stein; David F Penson; Jie Cai; Gus Miranda; Eila C Skinner; Matt A Dunn; Susan Groshen; Gary Lieskovsky; Donald G Skinner
Radical cystectomy with extended lymphadenectomy: evaluating separate package versus en bloc submission for node positive bladder cancer.
The Journal of urology 2007;177(3):876-81; discussion 881-2.
2006: David M Latini; June M Chan; Janet E Cowan; Shelley A Arredondo; Christopher J Kane; David F Penson; Janeen DuChane; Peter R Carroll
Health-related quality of life for men with prostate cancer and diabetes: a longitudinal analysis from CaPSURE.
Urology 2006;68(6):1242-7.
2006: David M Latini; David F Penson; Katrine L Wallace; Deborah P Lubeck; Tom F Lue
Longitudinal differences in psychological outcomes for men with erectile dysfunction: results from ExCEED.
The journal of sexual medicine 2006;3(6):1068-76.
2006: David M Latini; David F Penson; Katrine L Wallace; Deborah P Lubeck; Tom F Lue
Clinical and psychosocial characteristics of men with erectile dysfunction: baseline data from ExCEED.
The journal of sexual medicine 2006;3(6):1059-67.
2006: Kristin M Sanderson; David F Penson; Jie Cai; Susan Groshen; John P Stein; Gary Lieskovsky; Donald G Skinner
Salvage radical prostatectomy: quality of life outcomes and long-term oncological control of radiorecurrent prostate cancer.
The Journal of urology 2006;176(5):2025-31; discussion 2031-2.
2006: Claire C Yang; Michael P Porter; David F Penson
Comparison of the International Index of Erectile Function erectile domain scores and nocturnal penile tumescence and rigidity measurements: does one predict the other?
BJU international 2006;98(1):105-9; discussion 109.
2006: David F Penson; Judd W Moul; Sanjay Gandhi; Don Newling
Use of prostate-specific antigen in the follow-up of patients with localized prostate cancer: results of a nationwide survey of urologists.
Urology 2006;68(1):80-4.
2006: Peter C Black; David F Penson
Prostate cancer on the Internet--information or misinformation?
The Journal of urology 2006;175(5):1836-42; discussion 1842.
2005: David F Penson; Scott Ramsey; David Veenstra; Lauren Clarke; Sanjay Gandhi; Mark Hirsch
The cost-effectiveness of combined androgen blockade with bicalutamide and luteinizing hormone releasing hormone agonist in men with metastatic prostate cancer.
The Journal of urology 2005;174(2):547-52; discussion 552.
2005: David F Penson
An update on randomized clinical trials in localized and locoregional prostate cancer.
Urologic oncology 2005;23(4):280-8.
2005: Marcus L Quek; David F Penson
Quality of life in patients with localized prostate cancer.
Urologic oncology 2005;23(3):208-15.
2005: Michael P Porter; John T Wei; David F Penson
Quality of life issues in bladder cancer patients following cystectomy and urinary diversion.
The Urologic clinics of North America 2005;32(2):207-16.
2005: David F Penson; Dale McLerran; Ziding Feng; Lin Li; Peter C Albertsen; Frank D Gilliland; Ann Hamilton; Richard M Hoffman; Robert A Stephenson; Arnold L Potosky; Janet L Stanford
5-year urinary and sexual outcomes after radical prostatectomy: results from the prostate cancer outcomes study.
The Journal of urology 2005;173(5):1701-5.
2005: Michael P Porter; David F Penson
Health related quality of life after radical cystectomy and urinary diversion for bladder cancer: a systematic review and critical analysis of the literature.
The Journal of urology 2005;173(4):1318-22.
2005: Sung Hyun Paick; Alan Meehan; Michael Lee; David F Penson; Hunter Wessells
The relationship among lower urinary tract symptoms, prostate specific antigen and erectile dysfunction in men with benign prostatic hyperplasia: results from the proscar long-term efficacy and safety study.
The Journal of urology 2005;173(3):903-7.
2004: Terri Kang Johnson; Frank D Gilliland; Richard M Hoffman; Dennis Deapen; David F Penson; Janet L Stanford; Peter C Albertsen; Ann S Hamilton
Racial/Ethnic differences in functional outcomes in the 5 years after diagnosis of localized prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(20):4193-201.
2004: Arnold L Potosky; William W Davis; Richard M Hoffman; Janet L Stanford; Robert A Stephenson; David F Penson; Linda C Harlan
Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study.
Journal of the National Cancer Institute 2004;96(18):1358-67.
2004: Lurdes Y T Inoue; Ruth Etzioni; Elizabeth Slate; Christopher Morrell; David F Penson
Combining longitudinal studies of PSA.
Biostatistics (Oxford, England) 2004;5(3):483-500.
2004: David F Penson; Judd W Moul; Christopher P Evans; John J Doyle; Sanjay Gandhi; Lois Lamerato
The economic burden of metastatic and prostate specific antigen progression in patients with prostate cancer: findings from a retrospective analysis of health plan data.
The Journal of urology 2004;171(6 Pt 1):2250-4.
2003: Matthew Cooperberg; Deborah P Lubeck; David F Penson; Shilpa S Mehta; Peter R Carroll; Christopher J Kane
Sociodemographic and clinical risk characteristics of patients with prostate cancer within the Veterans Affairs health care system: data from CaPSURE.
The Journal of urology 2003;170(3):905-8.
2003: Lora A Plaskon; David F Penson; Thomas L Vaughan; Janet L Stanford
Cigarette smoking and risk of prostate cancer in middle-aged men.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2003;12(7):604-9.
2003: David F Penson; Mark S Litwin; Neil K Aaronson
Health related quality of life in men with prostate cancer.
The Journal of urology 2003;169(5):1653-61.
2003: David F Penson; David M Latini; Deborah P Lubeck; Katrine L Wallace; James M Henning; Tom F Lue
Do impotent men with diabetes have more severe erectile dysfunction and worse quality of life than the general population of impotent patients? Results from the Exploratory Comprehensive Evaluation of Erectile Dysfunction (ExCEED) database.
Diabetes care 2003;26(4):1093-9.
2003: David F Penson; David M Latini; Deborah P Lubeck; Katrine Wallace; James M Henning; Tom F Lue
Is quality of life different for men with erectile dysfunction and prostate cancer compared to men with erectile dysfunction due to other causes? Results from the ExCEED data base.
The Journal of urology 2003;169(4):1458-61.
2003: David M Latini; David F Penson; Deborah P Lubeck; Katrine L Wallace; James M Henning; Tom F Lue
Longitudinal differences in disease specific quality of life in men with erectile dysfunction: results from the Exploratory Comprehensive Evaluation of Erectile Dysfunction study.
The Journal of urology 2003;169(4):1437-42.
2003: David F Penson; Ziding Feng; Alan Kuniyuki; Dale McClerran; Peter C Albertsen; Dennis Deapen; Frank Gilliland; Richard Hoffman; Robert A Stephenson; Arnold L Potosky; Janet L Stanford
General quality of life 2 years following treatment for prostate cancer: what influences outcomes? Results from the prostate cancer outcomes study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(6):1147-54.
2002: David F Penson; A David Paltiel; Harlan Krumholz; Steven Palter
The cost-effectiveness of treatment for varicocele related infertility.
The Journal of urology 2002;168(6):2490-4.
2002: David M Latini; David F Penson; Hilary H Colwell; Deborah P Lubeck; Shilpa S Mehta; James M Henning; Tom F Lue
Psychological impact of erectile dysfunction: validation of a new health related quality of life measure for patients with erectile dysfunction.
The Journal of urology 2002;168(5):2086-91.
2002: Michael P Porter; Lynda F Voigt; David F Penson; Noel S Weiss
Racial variation in the incidence of squamous cell carcinoma of the bladder in the United States.
The Journal of urology 2002;168(5):1960-3.
2002: David F Penson; Peter C Albertsen
Lessons learnt about early prostate cancer from large scale databases: population-based pearls of wisdom.
Surgical oncology 2002;11(1-2):3-11.
2002: Richard Lee; David F Penson
Treatment outcomes in localized prostate cancer: a patient-oriented approach.
Seminars in urologic oncology 2002;20(1):63-73.
2001: David F Penson; P C Albertsen; Peter S Nelson; M Barry; Janet L Stanford
Determining cause of death in prostate cancer: are death certificates valid?
Journal of the National Cancer Institute 2001;93(23):1822-3.
2001: Deborah P Lubeck; H Kim; Gary D Grossfeld; P Ray; David F Penson; SC Flanders; Peter R Carroll
Health related quality of life differences between black and white men with prostate cancer: data from the cancer of the prostate strategic urologic research endeavor.
The Journal of urology 2001;166(6):2281-5.
2001: David F Penson; Mitchell Stoddard; David J Pasta; Deborah P Lubeck; SC Flanders; Mark S Litwin
The association between socioeconomic status, health insurance coverage, and quality of life in men with prostate cancer.
Journal of clinical epidemiology 2001;54(4):350-8.
2001: David F Penson; Warren H Schonfeld; SC Flanders; Curtis J Henke; KL Warolin; Peter R Carroll; Mark S Litwin
Relationship of first-year costs of treating localized prostate cancer to initial choice of therapy and stage at diagnosis: results from the CAPSURE database.
Urology 2001;57(3):499-503.
2000: J M Corman; David F Penson; Kwan Hur; S F Khuri; J Daley; W Henderson; J N Krieger
Comparison of complications after radical and partial nephrectomy: results from the National Veterans Administration Surgical Quality Improvement Program.
BJU international 2000;86(7):782-9.